CARDIOL THERAPEUTICS INC-A (CRDL)

CA14161Y2006 - Common Stock

2.0261  +0.05 (+2.33%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.0080.00K0.00
Operating Expenses
30.86M29.79M41.34M38.74M20.69M
Research and Development
15.81M14.22M18.96M10.87M10.52M
Selling, General, and Administrative Expenses
14.81M15.31M22.15M27.65M9.95M
Operating Income
-30.86M-29.79M-41.34M-38.66M-20.69M
Interest Income/Expense
2.70M1.51M10.24M6.91M40.00K
Other Income/Expense
N/A149.74K160.00K110.00K10.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-28.01M-28.13M-30.93M-31.64M-20.64M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-28.01M-28.13M-30.93M-31.64M-20.64M
EBITDA
-30.62M-29.54M-41.12M-38.44M-20.46M
 
Per Share Data
EPS Diluted Total Ops
-0.44-0.44-0.49-0.73-0.69
Non GAAP EPS
-0.44-0.44-0.49N/AN/A
 
Statistics
Profit Margin
N/AN/AN/A-39550.00%N/A
Operating Profit Margin
N/AN/AN/A-48325.00%N/A

All data in CAD

Charts